US Market Report: 2022 Market Size Reached $88b; 2025 to See Juul Rebound

Market
Jan.09.2023

Research and Markets, a consulting and research firm, released a report on the US tobacco market on Jan. 6. 

 

According to the report, the market size of the tobacco industry of the US reached $88.1 billion last year and is projected to exceed $110 billion in 2027 at a CAGR of 4.65%. In comparison, China's tobacco market size (cigarette and vape - since HnB is now prohibited in China) is an estimated $75.2 billion. 

 

US Market Report: 2022 Market Size Reached $88b; 2025 to See Juul Rebound
Source: research and markets

 

Market Segmentation Analysis:

  • By Product: The report provides the bifurcation of the market into five segments based on the product: cigarette, vaping products, moist snuff tobacco (MST), cigar & cigarillos and nicotine pouches. In 2021, in terms of both value and volume, the cigarette segment held a major share in the market, followed by vaping products. The future of the vaping market looks promising with the rising awareness about vaping products being safer than traditional cigarettes, especially among the younger population. On the other hand, the nicotine pouches segment is expected to grow at a significant CAGR in the forthcoming years owing to the growing interest in alternative products.
  • By Distribution Channel: The report provides the bifurcation of the market into into two segments based on the distribution channel: Offline and online. In 2021, offline segment held a major share in the market. Both small and large-scale companies sell their products through offline retail channels due to a large consumer base such as in grocery stores. The online channel is expected to register the highest CAGR during forecasted years owing to increase in spending on advertising and promotion by leading players operating in the market, thus offering significant growth to the segment in the forthcoming years.

 

Market Dynamics:

  • Growth Drivers: One of the most important factors impacting the US nicotine market is the growing number of smokers and upsurge in working population. As the lifestyles are centered around work and offices, stress and anxiety levels are growing among working individuals, which leads to growing consumption of stress relieving agents such as nicotine. Furthermore, the market has been growing over the past few years, due to factors such as rising income of individuals, growing popularity of e-cigarettes, shift towards next generation products, peer influence on youngsters, increased investment in research and development (R&D) and many other factors.
  • Challenges: However, the market has been confronted with some challenges specifically, stringent regulations, increasing taxes on tobacco products, harmful effects of nicotine, etc.
  • Trends: The market is projected to grow at a fast pace during the forecast period, due to various latest trends such as increasing influence of social media, escalating influence of partying and pop culture, strong penetration of organized retail network, rising popularity of tobacco free oral nicotine etc. The rising popularity of partying and pub culture among millennials and working-class communities has especially fueled the demand for flavored and unflavored cigarettes. Furthermore, Social media is also being increasingly used to create awareness related to health benefits of switching to e-cigarettes and vapor products from combustible smoking. This has risen the accessibility and reachability of individuals towards different brands, thereby increasing the demand for non combustible nicotine products, which is estimated to help in the market expansion of nicotine in coming years.

 

Competitive Landscape:

The US nicotine market is concentrated due to the presence of a relatively small number of market participants. Altria is the market leader in Tobacco products and held a dominant share of the total nicotine industry.

 

The key players in the US nicotine market are:

  • British American Tobacco P.L.C. (BAT)
  • Turning Point Brands Inc.
  • Altria Group Inc. (Altria)
  • Scandinavian Tobacco Group
  • Imperial Brands PLC
  • Philip Morris International Inc. (PMI)
  • Swedish Match AB
  • JUUL Labs, Inc.
  • Swisher
  • Vector Group Ltd.

 

Altria is the US market leader with through its leadership in the cigarettes and MST segment. The Altria's share is expected to decline during forecasted years due to an unfavorable shift within the market to segments where Altria under-indexes, such as vaping, and some loss of share within the cigarettes and MST segments.

 

The Vapor category has experienced rapid changes in share and market leadership, with JUUL's leadership position eroded since its 2019 peak by strong BAT share gains led by Vuse Alto. On the other hand, JUUL by comparison is expected to witness its value share of the market to rise by 2025 despite losing share in the US vaping segment.

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it. 

U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
U.S. Convenience Stores Rebalance Backbar as Nicotine Pouches Outpace Cigarettes
As cigarette volumes continue to decline, U.S. convenience-store operators are reconfiguring backbar space to accommodate modern oral nicotine products such as nicotine pouches. Industry data show nicotine pouches have become one of the fastest-growing nicotine categories while generating higher margins for retailers.
Jun.12
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.
Jun.15
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18